← Back to Search

MyCaRe App for Cardiac Surgery Recovery (MyCaRe Trial)

N/A
Recruiting
Led By Tracey J Colella, PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age > 35 years
Undergoing traditional (sternotomy approach) coronary artery bypass graft (CABG) surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks post operative discharge
Awards & highlights

MyCaRe Trial Summary

This trial will test an app to help cardiac surgery patients navigate post-op care, improve patient outcomes and reduce health care costs.

Who is the study for?
The MyCaRe clinical trial is for individuals aged 35 or older who have had a traditional coronary artery bypass graft surgery without complications and stayed in the hospital for 4-8 days. Participants must understand study instructions, use an app/Fitbit, have home wifi, hear phone conversations well, and live in/near Toronto or be willing to mail back devices.Check my eligibility
What is being tested?
This pilot RCT tests the MyCaRe Android application designed to aid cardiac recovery post-surgery. It offers educational content, tracks wound healing and activity via photos and Fitbit data, improves patient-provider communication, and streamlines referrals to outpatient care.See study design
What are the potential side effects?
Since this intervention involves using an application rather than medication or invasive procedures, typical medical side effects are not expected. However, participants may experience issues related to technology use such as privacy concerns or stress from learning new tech.

MyCaRe Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 35 years.
Select...
I am having open-heart surgery to improve blood flow to my heart.
Select...
My hospital stay is expected to last 4 to 8 days.

MyCaRe Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks post operative discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks post operative discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Enrolment in cardiac rehabilitation

MyCaRe Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MyCaRe Android ApplicationExperimental Treatment1 Intervention
The MyCaRe mobile application (education and symptom monitoring which includes pain, mood scales, wound monitoring) and Fitbit accelerometer (steps walked, distance) will be provided to patients receiving intervention group allocation for the initial 6 to 8 weeks recovery post cardiac surgery. The patients will be provided a temporary loan mobile device loaded with MyCaRe and Fitbit Inspire 2 before leaving hospital. They will be asked to input data (pain, mood, wounds, activity, blood sugar, blood pressure) daily if possible in first 2 weeks and once weekly thereafter until 6 to 8 weeks or until entry to a cardiac rehabilitation program.
Group II: Usual CareActive Control1 Intervention
Patients receiving usual care are typically referred to CR at the time of discharge from the acute care center via paper or electronic systematic referral (completed by a physician or nurse practitioner). Additionally, a conversation with the patient regarding CR by a healthcare provider may occur, however this communication is not always a consistent occurrence. Once referred, patients will await contact from a CR program in their region/area and if actual program enrollment occurs, this usually happens between 8 to 10 weeks post discharge.

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,476 Previous Clinical Trials
485,140 Total Patients Enrolled
Toronto General HospitalOTHER
25 Previous Clinical Trials
15,414 Total Patients Enrolled
Tracey J Colella, PhDPrincipal InvestigatorUniversity Health Network, Toronto

Media Library

MyCaRe Clinical Trial Eligibility Overview. Trial Name: NCT02778165 — N/A
Cardiac Dysfunction Research Study Groups: Usual Care, MyCaRe Android Application
Cardiac Dysfunction Clinical Trial 2023: MyCaRe Highlights & Side Effects. Trial Name: NCT02778165 — N/A
MyCaRe 2023 Treatment Timeline for Medical Study. Trial Name: NCT02778165 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the highest amount of participants involved in this medical trial?

"Yes, the information available on clinicaltrials.gov affirms that this medical investigation is currently recruiting patients. It was originally released to the public domain on October 1st 2022, and most recently amended on May 24th 2023. The trial needs 40 participants to be recruited from one site."

Answered by AI

Are there any current openings for individuals to join this trial?

"Affirmative. Evidenced by the information on clinicaltrials.gov, this experiment is recruiting participants as of now. It was first posted in October 1st, 2022 and has been edited most recently on May 24th 2023. The trial seeks to enrol 40 patients from one location."

Answered by AI
Recent research and studies
~16 spots leftby Apr 2025